UTI Asset Management Company Ltd Valuation Turns Very Attractive Amid Market Volatility

Recent Market Performance and Price Movement

UTI AMC’s share price has experienced notable volatility in recent sessions, with a steep decline of 10.76% on 27 Apr 2026, closing at ₹924.50 from the previous close of ₹1,035.95. This drop brought the stock close to its 52-week low of ₹915.00, a stark contrast to its 52-week high of ₹1,494.95. The one-week return of the stock is down by 10.64%, significantly underperforming the Sensex’s modest 2.33% decline over the same period. Year-to-date, UTI AMC has declined 18.11%, compared to the Sensex’s 10.04% fall, reflecting sector-specific pressures and broader market concerns.

Valuation Metrics Signal Increasing Attractiveness

The most striking development is the change in UTI AMC’s valuation grade from fair to very attractive, driven primarily by its current P/E ratio of 25.11. This is notably lower than several key peers in the capital markets sector, many of which are classified as very expensive. For instance, Star Health Insurance trades at a P/E of 67.06, Anand Rathi Wealth at 74.78, and Go Digit General at 57.96. Even Aditya AMC and Angel One, both prominent players, have P/E ratios of 31.66 and 31.28 respectively, well above UTI AMC’s level.

Price-to-book value (P/BV) for UTI AMC stands at 2.80, which, while not the lowest in the sector, remains reasonable given the company’s return on equity (ROE) of 13.41%. This ROE figure indicates a solid capacity to generate profits from shareholders’ equity, supporting the valuation. The enterprise value to EBITDA (EV/EBITDA) ratio is 14.67, again lower than many peers, suggesting that the company is trading at a discount relative to its earnings before interest, taxes, depreciation and amortisation.

Financial Strength and Profitability Metrics

UTI AMC’s return on capital employed (ROCE) is robust at 21.95%, underscoring efficient use of capital in generating operating profits. The dividend yield of 5.02% adds an attractive income component for investors, especially in a low-interest-rate environment. The EV to capital employed ratio of 2.98 further highlights the company’s efficient capital structure and operational leverage.

Comparative Analysis with Peers

When compared to its peers, UTI AMC’s valuation metrics stand out as compelling. Most competitors in the capital markets sector are trading at significantly higher multiples, reflecting either stronger growth expectations or overvaluation. For example, New India Assurance and Nuvama Wealth are trading at P/E ratios of 22.61 and 23.86 respectively, but are still rated as very expensive. The PEG ratio for UTI AMC is 0.00, which may indicate either a lack of growth estimates or an undervaluation relative to growth potential, contrasting with peers like Aditya AMC (PEG 6.62) and Anand Rathi Wealth (PEG 2.33).

Stock Rating and Market Capitalisation Context

Despite the attractive valuation, UTI AMC’s overall Mojo Score is 41.0, with a Mojo Grade of Sell, downgraded from Hold on 20 Apr 2026. This rating reflects caution due to recent price weakness and sector headwinds. The company is classified as a small-cap, which typically entails higher volatility and risk compared to larger peers. Investors should weigh the valuation appeal against the broader market and sector outlook.

Long-Term Performance Versus Sensex

Over longer horizons, UTI AMC has delivered strong returns relative to the Sensex. The three-year return of 37.79% outpaces the Sensex’s 27.65%, while the five-year return of 63.09% slightly exceeds the Sensex’s 60.12%. This track record of outperformance suggests that the company has underlying operational strengths that may support a recovery in share price over time. However, the one-year return of -17.72% compared to the Sensex’s -3.93% highlights recent challenges that have weighed on investor sentiment.

Valuation Shifts and Investor Implications

The shift from a fair to a very attractive valuation grade is a key development for investors seeking value opportunities in the capital markets sector. The current P/E and EV/EBITDA multiples suggest that UTI AMC is trading at a discount to its historical averages and peer group, potentially offering a margin of safety. The dividend yield above 5% further enhances the stock’s appeal for income-focused investors.

However, the downgrade in Mojo Grade to Sell signals that caution is warranted. Market participants should consider the reasons behind the recent price decline, including sector-specific risks, regulatory changes, or broader economic factors impacting asset management companies. A thorough analysis of earnings quality, asset under management trends, and competitive positioning remains essential before committing capital.

Conclusion: Valuation Opportunity Amid Volatility

UTI Asset Management Company Ltd’s recent valuation adjustment to a very attractive level presents a compelling case for value investors willing to navigate short-term volatility. The stock’s lower P/E and EV/EBITDA multiples relative to peers, combined with solid profitability metrics such as ROCE and ROE, underpin the investment thesis. Nevertheless, the downgrade to a Sell rating and recent price weakness highlight the need for careful risk assessment.

Investors should monitor upcoming quarterly results, sector developments, and broader market trends to gauge whether the valuation discount translates into sustainable share price appreciation. For those with a longer investment horizon, UTI AMC’s historical outperformance and dividend yield may offer a rewarding opportunity if the company can stabilise and grow its asset base in a competitive environment.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today